4D Molecular Therapeutics competitorsClear all

4D Molecular Therapeutics's top competitors include Intellia Therapeutics, Nzomics Biocatalysis, NTrans Technologies and Centrillion Technologies.
4D Molecular Therapeutics
4D Molecular Therapeutics
4D Molecular Therapeutics is a company focused on creation of gene therapy products to cure genetic diseases.
Intellia Therapeutics
Intellia Therapeutics
Intellia is developing therapeutic products to help people with genetic diseases.
Nzomics Biocatalysis
Nzomics Biocatalysis
Nzomics Biocatalysis is a company that supplies custom-made enzymes.
NTrans Technologies
NTrans Technologies
NTrans Technologies is a company developing a proprietary platform for the intracellular delivery of bioactive molecules.
Centrillion Technologies
Centrillion Technologies
Centrillion Technologies (formerly Centrillion Biosciences) is a company providing tools for genomic studies.
Founding Date
Founding Date
2013
Founding Date
2014
Founding Date
N/A
Founding Date
2015
Founding Date
2009
Type
Type
Private
Type
Public
Type
Private
Type
Private
Type
Subsidiary
Tags
Locations
Locations
Emeryville, US HQ
Locations
Cambridge, US HQ
Locations
HQ
Locations
Utrecht, NL HQ
Locations
Palo Alto, US HQ
Employees
Employees
881% increase
Employees
27028% increase
Employees
N/A
Employees
3
Employees
422% decrease
Twitter followers
Twitter followers
121
Twitter followers
5 k
Twitter followers
N/A
Twitter followers
99
Twitter followers
76
Alexa Website Rank
Alexa Website Rank
248429
Alexa Website Rank
264531
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Alexa Website Rank
377722
Employee Rating
Employee Rating
5
Employee Rating
3.6
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
2.2

Financial

Revenue (est.)
Revenue (est.)
$14.1m (FY, 2018)
Revenue (est.)
$43.1m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
($9.6m) (FY, 2018)
Net income
($99.5m) (FY, 2019)
Net income
N/A
Net income
N/A
Net income
N/A

Funding

Latest funding round
Latest funding round
$ 90m (about 2 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 1.6m (almost 4 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 100m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 1.6m
Total funding raised
$ 58.8m
For sources of this data, please see the company profile

View company profiles

Intellia Therapeutics
HQ
Cambridge, US
Employees
270↑ 28% increase

Intellia is developing therapeutic products to help people with genetic diseases.

View company
Nzomics Biocatalysis
HQ

Nzomics Biocatalysis is a company that supplies custom-made enzymes.

View company
NTrans Technologies
HQ
Utrecht, NL
Employees
3

NTrans Technologies is a company developing a proprietary platform for the intracellular delivery of bioactive molecules.

View company
Centrillion Technologies
HQ
Palo Alto, US

Centrillion Technologies (formerly Centrillion Biosciences) is a company providing tools for genomic studies.

View company